Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
US Army
Cipla
Baxter
Queensland Health

Generated: March 25, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Glimepiride; Pioglitazone Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00225264 Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. Completed Takeda Phase 3 The primary purpose of this study is to compare the effects of pioglitazone, once daily (QD), versus glimepiride on the amount of thickening of the carotid artery.
NCT00225277 Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus Completed Takeda Phase 3 The purpose of this study was to determine the efficacy of pioglitazone, once daily (QD), compared to glimepiride on atherosclerotic disease measured by intravascular ultrasound.
NCT00576784 Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin Completed IKFE Institute for Clinical Research and Development Phase 4 The goal of the study is to demonstrate whether a switch from insulin therapy to an oral therapy with pioglitazone/glimepiride will lead to a deterioration of glycemic control (increase in HbA1c by more than 0.5 %) within a 6 month observation period.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Glimepiride; Pioglitazone Hydrochloride

Condition Name

Condition Name for Glimepiride; Pioglitazone Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 5
Type 2 Diabetes Mellitus 5
Diabetes Mellitus 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Glimepiride; Pioglitazone Hydrochloride
Intervention Trials
Diabetes Mellitus 16
Diabetes Mellitus, Type 2 15
Insulin Resistance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Glimepiride; Pioglitazone Hydrochloride

Trials by Country

Trials by Country for Glimepiride; Pioglitazone Hydrochloride
Location Trials
United States 127
Germany 32
Canada 12
Italy 10
United Kingdom 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Glimepiride; Pioglitazone Hydrochloride
Location Trials
Pennsylvania 4
Illinois 4
Oklahoma 4
Tennessee 4
Texas 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Glimepiride; Pioglitazone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Glimepiride; Pioglitazone Hydrochloride
Clinical Trial Phase Trials
Phase 4 8
Phase 3 7
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Glimepiride; Pioglitazone Hydrochloride
Clinical Trial Phase Trials
Completed 12
Recruiting 3
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Glimepiride; Pioglitazone Hydrochloride

Sponsor Name

Sponsor Name for Glimepiride; Pioglitazone Hydrochloride
Sponsor Trials
Takeda 7
IKFE Institute for Clinical Research and Development 2
Pusan National University Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Glimepiride; Pioglitazone Hydrochloride
Sponsor Trials
Industry 13
Other 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Johnson and Johnson
Merck
Express Scripts
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.